Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Plaintiffs’ Attorneys Respond to Bayer’s Threat to Pull Roundup from Market

Bayer, Monsanto aim to protect its revenue “no matter the cost to human life”

Attorneys representing thousands of cancer victims criticized Bayer today for what they describe as an attempt to pressure courts, lawmakers and the public by threatening to pull its popular Roundup weedkiller from the market amid ongoing litigation.

Video of the plaintiffs’ attorneys’ reactions is available here.

Speaking at Bayer’s annual shareholders meeting, CEO Bill Anderson warned that continued lawsuits could make it financially unsustainable for the company to continue selling Roundup. The plaintiffs’ attorneys say the company’s remarks are not an acceptance of responsibility, but a calculated threat aimed at protecting Bayer’s financial interests at the expense of public health and accountability.

“Bayer’s CEO is using the threat of pulling Roundup as a blackmail attempt, pressuring legislators and the public to protect Bayer’s profits rather than holding the company accountable for the injuries it has caused,” said Nachawati Law Group partner Erin Wood, whose Dallas-based firm represents more than 5,000 cancer victims against the manufacturers. “This is a multibillion-dollar corporation doing everything it can to protect its revenue, no matter the cost to human life.”

The lawyers say Bayer’s multi-pronged strategy includes:

  • Pushing for federal preemption: earlier this month, Monsanto filed a petition asking the U.S. Supreme Court to rule that federal pesticide regulations preempt state law failure-to-warn claims, which would severely limit victims' ability to sue for injuries caused by Roundup.
  • State-level immunity legislation: Bayer and Monsanto are supporting bills in several states that would give pesticide companies immunity from lawsuits. These bills would block individuals harmed by pesticides, including cancer victims, from seeking compensation.
  • Selective settlements: even as Bayer warns publicly about the financial pressure of litigation, it continues to settle some cases while pursuing strategies to limit its overall liability.

According to trial evidence, Monsanto has long downplayed known cancer risks associated with exposure to glyphosate, the main ingredient in Roundup, while working behind the scenes to influence scientific research and avoid adding warning labels.

“The safety of American citizens is not for sale,” said firm founder Majed Nachawati. “Although we are aware of Bayer and Monsanto’s efforts to influence legislation to shield them from accountability, our firm will continue to fight tooth and nail in the legislature and in court to protect the legal rights of every citizen.”

Mr. Nachawati and his team have been a leading voice in opposing Monsanto’s efforts to sidestep accountability for thousands of cancer claims tied to Roundup.

To date, Bayer has reportedly spent more than $10 billion to settle thousands of cancer claims. Despite repeated efforts to limit its liability, the company continues to face ongoing litigation, has secured shareholder approval for a potential capital raise to cover legal costs and has made a third request for intervention by the U.S. Supreme Court.

About Nachawati Law Group

Nachawati Law Group represents individuals in mass tort litigation, businesses and governmental entities in contingent litigation and individual victims in complex personal injury litigation. For more information, visit https://ntrial.com

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.